Orphan Drugs: Research and Reviews
Volume 4, 2014 - Issue
Open access
192
Views
0
CrossRef citations to date
0
Altmetric
Review
A 30-year retrospective: National Organization for Rare Disorders, the Orphan Drug Act, and the role of rare disease patient advocacy groups
Mary DunkleNational Organization for Rare Disorders, Danbury, CT, USACorrespondence[email protected]
Pages 19-27
|
Published online: 17 Feb 2014
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.